首页> 外文期刊>Microbiologia Medica >Endotoxin activity dosage in septic patients
【24h】

Endotoxin activity dosage in septic patients

机译:败血病患者内毒素活性剂量

获取原文

摘要

Endotoxin (LPS), present in the outer membrane of Gram negative bacteria, is responsible for a series of biological effects, primarily linked to the lipid fraction (Lipid A).The aim of our work was to correlate the endotoxin activity with the risk of severe sepsis in patients showing severe bacterial infection and hospitalized in the three Intensive Care Units of the AUSL BAT. Fifty-three endotoxin activity (EA) blood tests were performed on 28 septic patients. 17/28 (60.7%) patients showed EA > 0.60 (associated with high risk of severe sepsis). Endotoxin activity (EA) blood tests were repeated in 11/17 cases after LPS removal by extracorporeal blood treatment with Polymyxin B (Toraymyxin). 6/11 patients had a reduction of LPS in the bloodstream after 1 treatment with Toraymyxin; in 5 of these 6 patients there was a further reduction after 2 treatments with Toraymyxin. EA dosage has been proven either a method for the diagnosis of severe sepsis due to Gram negative bacteria or helpful means in selecting patients for treatment with Toraymyxin.
机译:革兰氏阴性菌外膜中存在的内毒素(LPS)引起一系列生物学效应,主要与脂质组分(脂质A)有关。我们的工作目的是将内毒素活性与患病风险联系起来。表现为严重细菌感染的严重脓毒症患者,并已在AUSL BAT的三个重症监护病房住院。对28名败血症患者进行了53次内毒素活性(EA)血液检查。 17/28(60.7%)患者的EA> 0.60(伴有严重败血症的高风险)。在通过多粘菌素B(Toraymyxin)体外血液处理清除LPS后,对11/17例患者进行了内毒素活性(EA)血液检查。接受Toraymyxin治疗的患者中有6/11患者的血脂水平降低;在这6例患者中的5例中,使用Toraymyxin进行2次治疗后进一步降低。 EA剂量已被证明是诊断由革兰氏阴性细菌引起的严重败血症的方法,还是选择Toraymyxin治疗患者的有用手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号